Genopathy
Gene-Disorder Association · Article
Gene
CDKN2B
Cyclin Dependent Kinase Inhibitor 2B
Disorder
Lung Non-Small Cell Carcinoma
First reported 1995
Supporting publications 7
Key publication · gene–disorder Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.Cancer research · 1995
Key publication · disorder cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.Cancer treatment reports · 1979
Manually curated
Association Review

In brief

The association between CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) and Lung Non-Small Cell Carcinoma is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 0
Compounds 0
Trials 0
Publications 7
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CDKN2B

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Lung Non-Small Cell Carcinoma

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Literature

Reading

7 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
06
Provenance

References & sources

9 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access